Citalopram Hydrobromide
Product Images NDC 67046-110

This text provides results for subgroups in the MERIT-HF study, focusing on total mortality, all-cause hospitalization, and heart failure events. It compares the effects of metoprolol succinate and extended-release tablets versus placebo in different subgroups based on factors like NYHA classification, ejection fraction, etiology of heart failure, sex, race, and medical history. The data includes relative risk and 95% confidence intervals for each subgroup analyzed. The abbreviations used are explained such as US for United States, NYHA for New York Heart Association, EF for ejection fraction, MI for myocardial infarction, and HR for heart rate.*

A description of a medication product called Metoprolol Succinate Extended-Release Tablets, USP. Each tablet contains 190 mg of metoprolol succinate, USP, which is equivalent to 100 mg of metoprolol tartrate, USP. The usual dosage should be reviewed through the package insert. This prescription-only medicine is manufactured by Alkem Laboratories Ltd. in India for BluePoint Laboratories. The packaging includes 100 tablets. The storage temperature recommendation is listed as storing at 25°C (77°F), with permissible excursions between 15° to 30°C (59° to 86°F). A caution regarding keeping medications out of reach of children is provided. The detailed information about the product is highlighted, along with the manufacturing details and code information. Please refer to the package insert or consult a healthcare professional for proper usage guidance.*

This is a description of a medication package for film-coated tablets containing 23.75 mg of metoprolol succinate, USP equivalent to 25 mg of metoprolol. The tablets are extended-release and are for oral use only. It contains a warning to keep the medication out of the reach of children and to store it at 25°C (77°F). The manufacturer is Alkem Laboratories Ltd., located in India. It provides the NDC number, prescription information, and dosage guidelines.*